{
    "title": "Conformal Drug Property Prediction with Density Estimation under Covariate Shift. (arXiv:2310.12033v1 [cs.LG])",
    "abstract": "In drug discovery, it is vital to confirm the predictions of pharmaceutical properties from computational models using costly wet-lab experiments. Hence, obtaining reliable uncertainty estimates is crucial for prioritizing drug molecules for subsequent experimental validation. Conformal Prediction (CP) is a promising tool for creating such prediction sets for molecular properties with a coverage guarantee. However, the exchangeability assumption of CP is often challenged with covariate shift in drug discovery tasks: Most datasets contain limited labeled data, which may not be representative of the vast chemical space from which molecules are drawn. To address this limitation, we propose a method called CoDrug that employs an energy-based model leveraging both training data and unlabelled data, and Kernel Density Estimation (KDE) to assess the densities of a molecule set. The estimated densities are then used to weigh the molecule samples while building prediction sets and rectifying fo",
    "link": "http://arxiv.org/abs/2310.12033",
    "context": "Title: Conformal Drug Property Prediction with Density Estimation under Covariate Shift. (arXiv:2310.12033v1 [cs.LG])\nAbstract: In drug discovery, it is vital to confirm the predictions of pharmaceutical properties from computational models using costly wet-lab experiments. Hence, obtaining reliable uncertainty estimates is crucial for prioritizing drug molecules for subsequent experimental validation. Conformal Prediction (CP) is a promising tool for creating such prediction sets for molecular properties with a coverage guarantee. However, the exchangeability assumption of CP is often challenged with covariate shift in drug discovery tasks: Most datasets contain limited labeled data, which may not be representative of the vast chemical space from which molecules are drawn. To address this limitation, we propose a method called CoDrug that employs an energy-based model leveraging both training data and unlabelled data, and Kernel Density Estimation (KDE) to assess the densities of a molecule set. The estimated densities are then used to weigh the molecule samples while building prediction sets and rectifying fo",
    "path": "papers/23/10/2310.12033.json",
    "total_tokens": 851,
    "translated_title": "在协变量偏移下使用密度估计进行一致性药物属性预测",
    "translated_abstract": "在药物发现中，通过计算模型确认药品性质的预测需要进行昂贵的湿实验。因此，获取可靠的不确定性估计对于优先选择药物分子进行后续实验验证至关重要。一致性预测是一种有保证覆盖率的为分子性质创建预测集的有希望的工具。然而，在药物发现任务中，一致性预测的交换性假设往往会受到协变量偏移的挑战：大多数数据集包含有限的标记数据，这些数据可能不足以代表从中提取分子的庞大化学空间。为解决这个问题，我们提出了一种方法称为CoDrug，该方法使用基于能量的模型利用训练数据和无标记数据，并使用核密度估计来评估分子集合的密度。然后，利用估计的密度来加权分子样本以构建预测集并修正以下的",
    "tldr": "提出了一种名为CoDrug的方法，该方法利用基于能量的模型和核密度估计来解决协变量偏移问题，从而实现一致性药物属性预测。",
    "en_tdlr": "A method called CoDrug is proposed to address the issue of covariate shift in conformal drug property prediction, employing an energy-based model and kernel density estimation to achieve reliable uncertainty estimates."
}